Overview

The Efficacy of the Tailored Therapy Based on Antimicrobial Susceptibility for 2nd Eradication of H. Pylori

Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
As increasing the antibiotics resistance, the effectiveness of traditional Helicobacter pylori (H. pylori) therapies has been declined coincidently. In this study, the investigators evaluated the efficacy of H. pylori eradication between a personalized therapy for H. pylori infection based on the results of antibiotics resistance by using H. pylori culture and minimal inhibitory concentration (MIC) and the traditional 2nd rescue regimens, and the investigators analyzed the prevalence of the antibiotic resistance after 1st eradication of H. pylori in the tailored therapy group.
Phase:
N/A
Details
Lead Sponsor:
Seoul National University Bundang Hospital
Treatments:
Amoxicillin
Anti-Bacterial Agents
Anti-Infective Agents
Fluoroquinolones
Metronidazole
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination
Proton Pump Inhibitors
Tetracycline